Stem Cell Research (Feb 2024)

Generation of five induced pluripotent stem cell lines from patients with MECP2 Duplication Syndrome

  • Danielle Mendonca,
  • Gerarda Cappuccio,
  • Jennifer Sheppard,
  • Magdalena Delacruz,
  • Jesse Bengtsson,
  • Claudia M.B. Carvalho,
  • Aleksandar Bajic,
  • Hyekyung Park,
  • Jean J. Kim,
  • Paymaan Jafar-Nejad,
  • Christine Coquery,
  • Davut Pehlivan,
  • Bernhard Suter,
  • Mirjana Maletic-Savatic

Journal volume & issue
Vol. 74
p. 103292

Abstract

Read online

MECP2 Duplication Syndrome (MDS) is a rare, severe neurodevelopmental disorder arising from duplications in the Xq28 region containing the MECP2 gene that predominantly affects males. We generated five human induced pluripotent stem cell (iPSC) lines from the fibroblasts of individuals carrying between 0.355 and 11.2 Mb size duplications in the chromosomal locus containing MECP2. All lines underwent extensive testing to confirm MECP2 duplication and iPSC-related features such as morphology, pluripotency markers, and trilineage differentiation potential. These lines are a valuable resource for molecular and functional studies of MDS as well as screening for a variety of therapeutic approaches.